Back

HDL as potential therapeutic target.

8 July 2016 (15:40 - 16:00)
Organised by: Logo
Congress Presentation Part of: Biology of high-density lipoproteins: an update Atherosclerosis, thrombosis and vascular biology Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Thomas Felix Luescher

Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
HDL and cardiovascular protection: mechanistic insights.
Professor A. Kontush (Paris, FR)
Slides
Presentation thumbnail
Modulation of immune cell function by HDL.
Professor G. Norata (Milan, IT)
Presentation thumbnail
High density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-kB/STAT1-IRF1 signaling
Doctor E. van der Vorst (Aachen, DE)
Abstract
Presentation thumbnail
Protein components of HDL as markers of cardiovascular damage in patients with arterial hypertension
Mrs M. Mostovyak (Kiev, UA)
Abstract Slides

Access the full session

Session thumbnail
Biology of high-density lipoproteins: an update

The Event

Event poster

Frontiers in CardioVascular Biology 2016

8 July 2016 15:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources